GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors

NCT05430373 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors, Adult

Interventions

BIOLOGICAL: GT101

Sponsor

Grit Biotechnology